Tiny study tracks drug flow from leg implant
NCT ID NCT05208905
Summary
This small study aims to measure how much of the drug (everolimus) from a new artery scaffold gets into the bloodstream of patients with severe leg circulation problems. It will enroll about 9 people who have received the scaffold implant. Researchers will take many blood samples over 60 days to track the drug's levels and how long it stays in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL LIMB ISCHEMIA (CLI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ascension St. John Jane Phillips
Bartlesville, Oklahoma, 74006, United States
-
Charlton Memorial Hospital
South Dartmouth, Massachusetts, 02747, United States
-
First Coast Cardiovascular Institute
Jacksonville, Florida, 32256, United States
-
National Taiwan University Hospital
Taipei, Taiwan
-
Sir Charles Gairdner Hospital
Nedlands, WAUS, Australia
Conditions
Explore the condition pages connected to this study.